Beta Amyloid
Beta Amyloid inhibitors are compounds that target and prevent the formation or aggregation of beta-amyloid peptides, which are implicated in the pathogenesis of Alzheimer's disease. The accumulation of beta-amyloid plaques in the brain is a hallmark of the disease, leading to neuronal dysfunction and cognitive decline. Inhibitors of beta-amyloid aggregation are being explored as potential therapeutic agents to slow or prevent the progression of Alzheimer's disease. At CymitQuimica, we provide a range of beta-amyloid inhibitors to support your research in neurodegeneration, protein aggregation, and Alzheimer's therapy.
Found 240 products for "Beta Amyloid".
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Lecanemab
CAS:Lecanemab (BAN-2401) is an IgG1 monoclonal antibody targeting soluble aggregated beta amyloid (Abeta) for the study of cognitive disorders.Purity:95% - >95.0% (SDS-PAGE); 100% (SEC-HPLC)Color and Shape:Transparent LiquidMolecular weight:147.06 kDaEprodisate disodium
CAS:Eprodisate disodium (NC-503) is a negatively charged sulfonated inhibitor of fibrillogenesis, that can be used in the treatment of amyloid A (AA) amyloidosis.Formula:C3H6Na2O6S2Purity:99.88%Color and Shape:White Coarse PowderMolecular weight:248.19Glimepiride
CAS:Glimepiride (HOE-490) is a long-acting, third-generation sulfonylurea with hypoglycemic activity.Formula:C24H34N4O5SPurity:97.84% - 98.87%Color and Shape:White SolidMolecular weight:490.62Methoxy-X04
CAS:Methoxy-X04, a derivative of Congo red and Chrysamine-G, is a brain-permeable fluorescent probe for amyloid-β (Aβ).Formula:C23H20O3Purity:98.96%Color and Shape:SolidMolecular weight:344.4Ref: TM-T22972
1mg37.00€5mg79.00€1mL*10mM (DMSO)92.00€10mg123.00€25mg236.00€50mg416.00€100mg615.00€200mg874.00€Donanemab
CAS:Donanemab (LY3002813), a humanized IgG1 antibody, targets N-terminal Aβ for potential early Alzheimer's research.Purity:95%Color and Shape:Transparent LiquidMolecular weight:145.36 kDaCromolyn sodium
CAS:Cromolyn sodium (FPL-670) is a chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells.Formula:C23H14Na2O11Purity:99.4% - 99.95%Color and Shape:White SolidMolecular weight:512.33Birtamimab
CAS:Birtamimab (NEOD001) is a monoclonal antibody selectively targeting and depleting amyloid protein, used in research on light chain amyloidosis.Purity:>95%Color and Shape:Transparent LiquidMolecular weight:146.44 kDaGantenerumab
CAS:Gantenerumab (R-1450) is a humanized antibody targeting amyloid-β (Aβ), used in studies of Alzheimer's disease.Purity:>95%Color and Shape:Transparent LiquidMolecular weight:146.28 kDaChlorzoxazone
CAS:Chlorzoxazone (Chlorzoxazon) is a Muscle Relaxant. The physiologic effect of chlorzoxazone is by means of Centrally-mediated Muscle Relaxation.Formula:C7H4ClNO2Purity:99.49% - 99.6%Color and Shape:White SolidMolecular weight:169.57ALZ-801
CAS:ALZ-801, an oral valine-prodrug of tramiprosate, enhances treatment of Alzheimer's by inhibiting β-amyloid aggregation with better PK and tolerance.Formula:C8H18N2O4SPurity:99.36%Color and Shape:SolidMolecular weight:238.3LY 2389575 hydrochloride
CAS:LY2389575 hydrochloride is a selective mGlu3 NAM with 190 nM IC50, increases Mrc1, and aids Alzheimer's research.Formula:C15H16BrCl3N4Purity:99.9%Color and Shape:SolidMolecular weight:438.58β-Amyloid (1-28)
CAS:β-Amyloid (1-28) is a β-Amyloid protein fragment involved in metal binding.Formula:C145H209N41O46Purity:98%Color and Shape:SolidMolecular weight:3262.51Davunetide
CAS:Davunetide: neuroprotective 8-amino acid peptide, improves daily function in schizophrenia, boosts memory in mild cognitive impairment.Formula:C36H60N10O12Purity:98%Color and Shape:SolidMolecular weight:824.92γ-Secretase Modulators
CAS:gamma-Secretase Modulators serves as a useful treatment for Alzheimer's disease by inhibiting the production of Amyloid-β.Formula:C26H24F3N3O3Purity:98%Color and Shape:SolidMolecular weight:483.481H-Indole-3-carboxylic acid, 5-[2-hydroxy-3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]propoxy]-2-methyl-1-(4-methylphenyl)-, ethyl ester
CAS:Compound 5936-0108对β-淀粉样蛋白可能具有调节作用。Formula:C26H34N2O7Purity:99.33%Color and Shape:SoildMolecular weight:486.56Ref: TM-T67751
1mg296.00€5mg718.00€1mL*10mM (DMSO)895.00€10mg982.00€25mg1,485.00€50mg2,008.00€100mg2,637.00€CHF-5022
CAS:CHF-5022 is a nonsteroidal anti-inflammatory drug that selectively inhibits the production of beta-amyloid protein (1-42) (ABETA42).Formula:C17H12F4O2Color and Shape:SolidMolecular weight:324.27SQ-3
SQ-3, a quinoline analogue, prefers α-syn (Ki=39.3nM) to Aβ (Ki=230nM), and [18F]SQ3 is a lead for α-syn probes. [1]Formula:C21H21FN2OColor and Shape:SolidMolecular weight:336.4BIBD-124
CAS:BIBD-124, with an IC50 value of 9.51 nM, effectively binds to amyloid beta (Aβ) plaques.Formula:C19H24FN3O3Color and Shape:SolidMolecular weight:361.41Nivegacetor
CAS:Nivegacetor(RG6289) is a selective and orally administrable γ-secretase regulator that can affect the production of amyloid-β in cerebrospinal fluid.Formula:C23H25F2N7O2Purity:99.84%Color and Shape:Yellow SolidMolecular weight:469.49Sabirnetug
CAS:Sabirnetug is a humanized IgG2κ monoclonal antibody that specifically targets the amyloid-β (A4) precursor protein.Color and Shape:LiquidRAGE antagonist peptide
CAS:RAGE antagonist blocks S100P/A4, HMGB-1; hinders glioma growth, metastasis; reduces PDAC cell growth, NF-κB activity; counters TDI effects in mice.Formula:C57H101N13O17SPurity:98%Color and Shape:SolidMolecular weight:1272.56Aβ-IN-6
Aβ-IN-6 is an orally active compound exhibiting anti-inflammatory, antioxidant, and anti-oligomeric activities, with significant implications for Alzheimer'sFormula:C28H31N3O4Color and Shape:SolidMolecular weight:473.56β Amyloid(28-35) human
CAS:β-Amyloid(28-35) human is a neurotoxic β-amyloid peptide fragment that contributes to Alzheimer's disease pathogenesis by interacting with neuronal membranes,Formula:C36H67N9O9SColor and Shape:SolidMolecular weight:802.04Amyloid β-Protein (1-46)
CAS:Amyloid β-Protein (1-46) is a segment of the Aβ peptide.Formula:C223H347N59O65SColor and Shape:SolidMolecular weight:4923.53817APP669-711
APP669-711 is a peptide fragment comprising amino acids 669 to 711 of the amyloid precursor protein (APP). This peptide serves as a biomarker in Alzheimer's disease (AD) research and is useful for diagnosing amyloid deposition in the brain.Formula:C210H325N57O61S2Molecular weight:4685.35229Amyloid β-Protein (16-22)
CAS:Amyloid β-Protein (16-22) is a segment of the Aβ peptide.Formula:C43H64N8O10Molecular weight:853.02(Gly22)-amyloid β-protein(1-40)
CAS:Amyloid beta-protein(1-40) Arctic variant (Ab40ARC (E22G)), featuring a glycine at position 22 (Gly22), is a peptide utilized in Alzheimer's disease research [1Color and Shape:SolidAducanumab
CAS:Aducanumab (BIIB037) is an IgG1 antibody targeting amyloid beta to treat Alzheimer's; it's brain-permeable.Purity:95% - 97.10%Color and Shape:Transparent LiquidMolecular weight:145.93 kDaβ-Amyloid (33-40)
CAS:β-Amyloid (33-40) is a peptide comprising amino acids 33 to 40 of the beta-amyloid protein.Formula:C32H58N8O9SPurity:98%Color and Shape:SolidMolecular weight:730.92β-Amyloid (4-10)
CAS:Antibodies corresponding to beta-amyloid (4-10) are effective in vivo inhibitors of cytotoxicity, amyloid plaque formation and special memory disturbances inFormula:C39H52N12O12Purity:98%Color and Shape:SolidMolecular weight:880.9β-Amyloid (29-40)
CAS:β-Amyloid (29-40) is a fragment of Amyloid-β peptide.Alzheimer's beta amyloid peptide (29-40/42) C-terminal fragments have physical and chemical propertiesFormula:C49H88N12O13SPurity:98%Color and Shape:SolidMolecular weight:1085.36β-Amyloid (1-34)
CAS:This is a fragment of beta-amyloid peptide. It has amino acids 1 through 34.Formula:C170H253N47O52Purity:98%Color and Shape:SolidMolecular weight:3787.25-TAMRA-Amyloid β-Protein (1-40)
CAS:5-TAMRA-Amyloid β-Protein (1-40) is a TAMRA-labeled variant of Amyloid β-Protein (1-40), featuring an absorption/emission spectrum at 544/572 nm [1].Color and Shape:Solid(Gln22)β-Amyloid (1-40) human
(Gln22)β-Amyloid (1-40) human is a peptide containing amyloid β-protein (Aβ), which can be utilized in Alzheimer's disease research.Formula:C194H296N54O57SMolecular weight:4326.16441β-Amyloid (10-35), amide
CAS:β-Amyloid (10-35), amide, is a chemical compound consisting of 26 amino acids, specifically residues 10-35 of the Aβ peptide.Formula:C133H205N35O36SPurity:98%Color and Shape:SolidMolecular weight:2902.33β-Amyloid (1-40)
CAS:Amyloid β1-40 is one of the fragments generated after cleavage of the amyloid peptide precursor protein by β and γ secretases.Formula:C194H295N53O58SPurity:98%Color and Shape:SolidMolecular weight:4329.825-FAM-β-Amyloid (1-28)
5-FAM-β-Amyloid (1-28) is a fluorescently-labeled peptide corresponding to the first 28 amino acids of the β-Amyloid protein.Formula:C166H219N41O52Color and Shape:SolidMolecular weight:3620.76LPYFD-NH2
CAS:neuroprotective peptide that binds to amyloid beta (Aβ)Formula:C33H44N6O8Purity:98%Color and Shape:SolidMolecular weight:652.74β-Amyloid (22-35)
CAS:β-Amyloid (22-35) is a 14-aa peptide, shows aggregates and induces neurotoxicity in the hippocampal cells.Formula:C59H102N16O21SPurity:98%Color and Shape:SolidMolecular weight:1403.62β-Amyloid (22-40)
CAS:This synthetic peptide consists of amino acids 22 to 40 of beta amyloid protein.Formula:C78H135N21O26SPurity:98%Color and Shape:SolidMolecular weight:1815.1SAR228810
SAR228810 is a humanized IgG4 monoclonal antibody inhibitor targeting amyloid beta (Aβ), with a dissociation constant (KD) of 0.43 nM for fibrillar Aβ, which is higher than for monomeric Aβ. It significantly hinders brain amyloid plaque formation, oligomer-induced synaptic dysfunction, and neuronal loss. Furthermore, SAR228810 offers substantial protection against Aβ-mediated neurotoxicity. MINT1526A is applicable in Alzheimer's disease imaging and immunotherapy research.Color and Shape:Odour LiquidFITC-β-Ala-β-Amyloid (25-35)
FITC-β-Ala-β-Amyloid (25-35) is a FITC-labeled fluorescent compound utilized in Alzheimer's disease research [1].Color and Shape:Odour Solidβ-Amyloid (13-27)
CAS:β-Amyloid (13-27) is a peptide consisting of amino acid of 13 to 27 of beta amyloid protein.Formula:C84H126N24O24Purity:98%Color and Shape:SolidMolecular weight:1856.05β-Amyloid (1-16)
CAS:β-Amyloid (1-16) is an amyloidogenic protein fragment with a sequence derived from β-amyloid.Formula:C84H119N27O28Purity:98%Color and Shape:SolidMolecular weight:1955.04QSH peptide
CAS:The QSH peptide is a polypeptide that specifically binds to Aβ1-42, and is employed in the synthesis of siRNA delivery complexes. It is applicable in research related to Alzheimer's disease (AD).Formula:C62H95N21O18Molecular weight:1422.55β-Amyloid (12-28)
CAS:Amyloid β-peptide fragment; minimum section required to bind to brain proteins.Formula:C89H135N25O25Purity:98%Color and Shape:SolidMolecular weight:1955.18Chemerin-9 (149-157) TFA
Chemerin-9 (149-157) TFA is a peptide located at positions 149-157 of chemerin-9, acting as a ChemR23/CMKLR1 agonist.Formula:C56H67F3N10O15Purity:99.77%Color and Shape:White SolidMolecular weight:1177.18β-Amyloid Protein Precursor 770 (135-155)
CAS:Beta-Amyloid Protein Precursor 770 (135-155)Aβ Protein Precursor 770 (135-155)Formula:C116H172N35O31S2Purity:98%Color and Shape:SolidMolecular weight:2617.96Davunetide acetate
Davunetide acetate is derived from activity-dependent neuroprotective protein existing in the mammalian CNS.Formula:C38H64N10O14Purity:99.52% - 99.78%Color and Shape:SolidMolecular weight:884.97β-Amyloid (10-20)
CAS:Amyloid β-Protein (10-20) is a fragment of Amyloid-β peptide, maybe used in the research of neurological disease.Amyloid β protein fragment containing the α-Formula:C71H99N17O16Purity:98%Color and Shape:Lyophilized PowderMolecular weight:1446.65
![1H-Indole-3-carboxylic acid, 5-[2-hydroxy-3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]propoxy]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTM%2Fthumb-webp%2FT67751.webp&w=3840&q=75)
